| Literature DB >> 25701254 |
David F Finnegan1, Erin L Shelnut1, Spyros P Nikas1, Nan Chiang2, Charles N Serhan2, Alexandros Makriyannis3.
Abstract
We report the design and synthesis of novel prostaglandin-ethanolamide (PGE2-EA) analogs containing head and tail group modifications to aid in the characterization of a putative prostamide receptor(s). Our synthetic approach utilizes Horner-Wadsworth-Emmons and Wittig reactions to construct the head and the tail moieties of the key PGE2 precursor, which leads to the final products through a peptide coupling, Swern oxidation and HF/pyridine assisted desilylation. The synthesized analogs were shown not to interact significantly with endocannabinoid proteins and recombinant EP1, EP3 and EP4 receptors and suggest a yet to be identified prostamide receptor as their site(s) of action.Entities:
Keywords: Cyclooxygenase-2; Endocannabinoids; Prostamides
Mesh:
Substances:
Year: 2015 PMID: 25701254 PMCID: PMC4405029 DOI: 10.1016/j.bmcl.2015.01.064
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823